Protagonist Therapeutics Inc. (PTGX) Down After Hours Following Annual Meeting Notice Filing
On April 13, 2022, Protagonist Therapeutics Inc. (PTGX) filed a notice of the Annual Meeting of Stockholders with the SEC. The stock while gaining 8.32% in the regular trading session, declined by a huge 31.43% in the after-hours. Thus, after closing the regular session at a price of $25.52, PTGX reached $17.50 per share in […]